Age and Computed Tomography and Invasive Coronary Angiography in Stable Chest Pain: A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Maria Bosserdt
  • Lina M Serna-Higuita
  • Gudrun Feuchtner
  • Bela Merkely
  • Kofoed, Klaus Fuglsang
  • Theodora Benedek
  • Patrick Donnelly
  • José Rodriguez-Palomares
  • Andrejs Erglis
  • Cyril Štechovský
  • Gintare Šakalyte
  • Nada Cemerlic Adic
  • Matthias Gutberlet
  • Jonathan D Dodd
  • Ignacio Diez
  • Gershan Davis
  • Elke Zimmermann
  • Cezary Kepka
  • Radosav Vidakovic
  • Marco Francone
  • Malgorzata Ilnicka-Suckiel
  • Fabian Plank
  • Juhani Knuuti
  • Rita Faria
  • Stephen Schröder
  • Colin Berry
  • Luca Saba
  • Balazs Ruzsics
  • Nina Rieckmann
  • Christine Kubiak
  • Kristian Schultz Hansen
  • Jacqueline Müller-Nordhorn
  • Bálint Szilveszter
  • Per E Sigvardsen
  • Imre Benedek
  • Clare Orr
  • Filipa Xavier Valente
  • Ligita Zvaigzne
  • Vojtech Suchánek
  • Antanas Jankauskas
  • Filip Adic
  • Michael Woinke
  • Mark Hensey
  • Iñigo Lecumberri
  • Erica Thwaite
  • Michael Laule
  • Mariusz Kruk
  • Charlotte Kragelund
  • Hove, Jens Dahlgaard
  • Linnea Larsen
  • DISCHARGE Trial Group
Importance The effectiveness and safety of computed tomography (CT) and invasive coronary angiography (ICA) in different age groups is unknown.

Objective To determine the association of age with outcomes of CT and ICA in patients with stable chest pain.

Design, Setting, and Participants The assessor-blinded Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial was conducted between October 2015 and April 2019 in 26 European centers. Patients referred for ICA with stable chest pain and an intermediate probability of obstructive coronary artery disease were analyzed in an intention-to-treat analysis. Data were analyzed from July 2022 to January 2023.

Interventions Patients were randomly assigned to a CT-first strategy or a direct-to-ICA strategy.

Main Outcomes and Measures MACE (ie, cardiovascular death, nonfatal myocardial infarction, or stroke) and major procedure-related complications. The primary prespecified outcome of this secondary analysis of age was major adverse cardiovascular events (MACE) at a median follow-up of 3.5 years.

Results Among 3561 patients (mean [SD] age, 60.1 [10.1] years; 2002 female [56.2%]), 2360 (66.3%) were younger than 65 years, 982 (27.6%) were between ages 65 to 75 years, and 219 (6.1%) were older than 75 years. The primary outcome was MACE at a median (IQR) follow-up of 3.5 (2.9-4.2) years for 3523 patients (99%). Modeling age as a continuous variable, age, and randomization group were not associated with MACE (hazard ratio, 1.02; 95% CI, 0.98-1.07; P for interaction = .31). Age and randomization group were associated with major procedure-related complications (odds ratio, 1.15; 95% CI, 1.05-1.27; P for interaction = .005), which were lower in younger patients.

Conclusions and Relevance Age did not modify the effect of randomization group on the primary outcome of MACE but did modify the effect on major procedure-related complications. Results suggest that CT was associated with a lower risk of major procedure-related complications in younger patients.
TidsskriftJAMA Cardiology
Udgave nummer4
Sider (fra-til)346-356
Antal sider11
StatusUdgivet - 2024

ID: 386144023